Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140
Status:
Terminated
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine eligibility for one of three treatment studies of
the CCR5 antagonist GW873140 or an observational study without GW873140. No investigational
treatment will be administered through this study.